Friday, 2 October 2026NewsWorldBusinessTech
Latest

Merck Withdraws Recarbrio Antibiotic From U.S. Market

Merck Withdraws Recarbrio Antibiotic From U.S. Market

Merck is halting U.S. production and distribution of Recarbrio, a specialized antibacterial combination drug designed to treat severe hospital-acquired infections and multidrug-resistant pathogens. The abrupt withdrawal…